Virtual coupling of pyran protons in the 1H NMR spectra of C- and N-glucoronides: Dependence on substitution and solvent
Journal Title: The AAPS Journal - Year 2001, Vol 3, Issue 1
Abstract
We have observed that certain C-and N-glucuronides prepared as intermediates for breast cancer preventives demonstrate non-first order 1H NMR spectra that are not the result of impurities or degradation but are instead due to virtual coupling in the pyran proton network. This virtual coupling shows the expected dependence on solvent and field strength and, more importantly, on the nature of the C-1 substitution. Although the hybridization of the atom bonded to C-1 may play a role, it appears that steric and/or electronic factors, which have the effect of increasing Δv/J for H-3 and H-4, are critical for eliminating the spectral complexity. These observations, which appear to be fairly general, suggest that this phenomenon should be considered when addressing the purity of pharmaceutical agents containing these types of structural units.
Authors and Affiliations
M. J. Panigot, M. J. Robarge, R. W. Curley
Keywords
Related Articles
- EP ID EP682017
- DOI 10.1208/ps030104
- Views 78
- Downloads 0
Modeling the Effects of Vaccination and Treatment on Pandemic Influenza
In this paper, we demonstrate the uses of some simple mathematical models for the study of disease dynamics in a pandemic situation with a focus on influenza. These models are employed to evaluate the effectiveness of va...
Species and Gender Differences Affect the Metabolism of Emodin via Glucuronidation
The aim of the present study was to define the mechanisms responsible for poor bioavailability of emodin by determining its metabolism using in vitro and in situ disposition models of the intestine and liver. Liver micro...
Estimation of Biliary Excretion of Foreign Compounds Using Properties of Molecular Structure
The online version of this article (doi:10.1208/s12248-013-9541-z) contains supplementary material, which is available to authorized users.
Interactions of Everolimus and Sorafenib in Pancreatic Cancer Cells
Everolimus targets the mammalian target of rapamycin, a kinase that promotes cell growth and proliferation in pancreatic cancer. Sorafenib inhibits the Raf-mitogen-activated protein kinase, vascular endothelial growth fa...
Evaluation of Physical and Chemical Changes in Pharmaceuticals Flown on Space Missions
The online version of this article (doi:10.1208/s12248-011-9270-0) contains supplementary material, which is available to authorized users.